ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Comprehensive Metabolomics Identified the Prominent Role of Glycerophospholipid Metabolism in Coronary Artery Disease Progression

Chen, Hui; Wang, Zixian; Qin, Min; Zhang, Bin; Lin, Lu; Ma, Qilin; Liu, Chen; Chen, Xiaoping; Li, Hanping; Lai, Weihua; Zhong, Shilong*广东省人民医院; 广东省心血管病研究所; 中山大学; 1
Frontiers in Molecular Biosciences2021-4-14DOI: 10.3389/fmolb.2021.632950
14被引13阅读
引用收藏
分享

摘要

Background: Coronary stenosis severity determines ischemic symptoms and adverse outcomes. The metabolomic analysis of human fluids can provide an insight into the pathogenesis of complex disease. Thus, this study aims to investigate the metabolomic and lipidomic biomarkers of coronary artery disease (CAD) severity and to develop diagnostic models for distinguishing individuals at an increased risk of atherosclerotic burden and plaque instability. @@@ Methods: Widely targeted metabolomic and lipidomic analyses of plasma in 1,435 CAD patients from three independent centers were performed. These patients were classified as stable coronary artery disease (SCAD), unstable angina (UA), and myocardial infarction (MI). Associations between CAD stages and metabolic conditions were assessed by multivariable-adjusted logistic regression. Furthermore, the least absolute shrinkage and selection operator logistic-based classifiers were used to identify biomarkers and to develop prediagnostic models for discriminating the diverse CAD stages. @@@ Results: On the basis of weighted correlation network analysis, 10 co-clustering metabolite modules significantly (p < 0.05) changed at different CAD stages and showed apparent correlation with CAD severity indicators. Moreover, cross-comparisons within CAD patients characterized that a total of 72 and 88 metabolites/lipid species significantly associated with UA (vs. SCAD) and MI (vs. UA), respectively. The disturbed pathways included glycerophospholipid metabolism, and cysteine and methionine metabolism. Furthermore, models incorporating metabolic and lipidomic profiles with traditional risk factors were constructed. The combined model that incorporated 11 metabolites/lipid species and four traditional risk factors represented better discrimination of UA and MI (C-statistic = 0.823, 95% CI, 0.783-0.863) compared with the model involving risk factors alone (C-statistic = 0.758, 95% CI, 0.712-0.810). The combined model was successfully used in discriminating UA and MI patients (p < 0.001) in a three-center validation cohort. @@@ Conclusion: Differences in metabolic profiles of diverse CAD subtypes provided a new approach for the risk stratification of unstable plaque and the pathogenesis decipherment of CAD progression.

学科与关键词

关键词
coronary artery diseasemetabolomelipidomeseverityglycerophospholipid metabolismdiagnostic marker
相关
加载中…

文献加载失败,请重试

重试

发表信息

论文状态
公开发表
期刊
Frontiers in Molecular Biosciences
发表日期
2021-04-14
卷期
第 8 卷
页码
632950
DOI
10.3389/fmolb.2021.632950
期刊收录
NSL
期刊等级
3区
成果收录
SCIE
资助标注
National Natural Science Foundation of China [81872934, 81673514]; Key-Area Research and Development Program of Guangdong Province, China [2019B020229003]; Science and Technology Planning Project of Guangdong Province, China [2017B030314041]

作者

  • C

    Chen, Hui (第一作者)

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • W

    Wang, Zixian

    guangdong prov peoples hosp · guangdong cardiovasc inst

查看全部 11 位作者收起作者
  • Q

    Qin, Min

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • Z

    Zhang, Bin

    guangdong prov peoples hosp · guangdong cardiovasc inst

  • L

    Lin, Lu

    guangdong prov peoples hosp

  • M

    Ma, Qilin

  • L

    Liu, Chen

    1 · sun yat sen univ

  • C

    Chen, Xiaoping

  • L

    Li, Hanping

    guangdong cardiovasc inst · guangdong prov peoples hosp

  • L

    Lai, Weihua

    guangdong prov peoples hosp

  • Z

    Zhong, Shilong (通讯)

    guangdong prov peoples hosp · guangdong cardiovasc inst

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417